HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$26.34
Day range
$23.10 - $25.82
Year range
$14.42 - $25.82
Market cap
638.30M USD
Avg Volume
150.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.94M | -34.84% |
Net income | -10.22M | 45.90% |
Net profit margin | — | — |
Earnings per share | -0.38 | — |
EBITDA | -12.94M | 34.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.11M | 146.28% |
Total assets | 224.01M | 143.02% |
Total liabilities | 8.73M | -49.30% |
Total equity | 215.28M | — |
Shares outstanding | 27.50M | — |
Price to book | 3.36 | — |
Return on assets | -15.17% | — |
Return on capital | -15.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.22M | 45.90% |
Cash from operations | -10.58M | 19.15% |
Cash from investing | -62.23M | -247.38% |
Cash from financing | 29.82M | 5,349.65% |
Net change in cash | -42.99M | -36.17% |
Free cash flow | -7.28M | — |
About
Founded
2020
Headquarters
Website
Employees
6
